赛马鲁肽
超重
肥胖
医学
内科学
内分泌学
糖尿病
2型糖尿病
利拉鲁肽
作者
W. Timothy Garvey,Matthias Blüher,Cristina Contreras,Melanie J. Davies,Eva Winning Lehmann,Kirsi H. Pietiläinen,Domenica Rubino,Paolo Sbraccia,Thomas A. Wadden,Niels Zeuthen,John Wilding
标识
DOI：10.1056/nejmoa2502081
摘要
Cagrilintide-semaglutide provided significant and clinically relevant body-weight reductions in adults with overweight or obesity, as compared with placebo. (Funded by Novo Nordisk; REDEFINE 1 ClinicalTrials.gov number, NCT05567796.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
识字岭的岭
无极微光
8R60d8
tiptip
蓝莓橘子酱
科研狗
dew
菠菜
916
Twonej
BowieHuang
Winfred
风吹麦田
挖掘机
pluto
Sea_U
乐空思
小黄人
子车茗
皖公网安备34019202002308
